ANAC

Anacor Pharmaceuticals, Inc. News Headlines

$33.21
*  
0.19
0.58%
Get ANAC Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading ANAC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ANAC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Anacor Pharmaceuticals' Sales Of Kerydin May Be Better Than Expected
11/21/2014 9:42:00 AM - Seeking Alpha


Anacor Announces Proposed Offering Of $70 Mln Convertible Senior Notes Due 2021
10/9/2014 12:54:00 AM - RTT News


Route Expansion, Collaborations to Boost GOL's Performance - Analyst Blog
9/24/2014 1:50:00 PM - Zacks.com


Anacor's Kerydin Launched in the US for Onychomycosis - Analyst Blog
9/23/2014 4:05:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 9/22/14: AEO, SEM, AXDX, MERC
9/23/2014 6:00:00 AM - Seeking Alpha


Anacor Announces U.S. Launch Of KERYDIN Topical Solution, 5%
9/22/2014 4:28:00 PM - RTT News


InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO
9/17/2014 11:01:00 AM - Seeking Alpha


Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog
9/16/2014 3:14:00 PM - Zacks.com


Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog
9/15/2014 2:42:00 PM - Zacks.com


Tuesday 9/9 Insider Buying Report: CMRX, ANAC
9/9/2014 11:09:15 AM - BNK Invest


InsiderInsights.com Daily Round Up 9/8/14: Nuverra Environmental Solutions, Tableau Software, Conn's, OPKO Health
9/9/2014 9:43:00 AM - Seeking Alpha


Astellas' Antifungal Under FDA Review, Response by Mar 2015 - Analyst Blog
9/8/2014 4:50:00 PM - Zacks.com


Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog
8/15/2014 8:00:00 AM - Zacks.com


Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog
8/14/2014 2:30:00 PM - Zacks.com


Anacor (ANAC) Shares March Higher, Can It Continue? - Tale of the Tape
8/13/2014 8:49:19 AM - Zacks.com


Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
8/13/2014 8:10:00 AM - Zacks.com


Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog
8/12/2014 9:50:00 AM - Zacks.com


Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus - Analyst Blog
8/12/2014 8:58:00 AM - Zacks.com


Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog
8/12/2014 8:20:00 AM - Zacks.com


ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog
8/11/2014 11:21:00 AM - Zacks.com


Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog
8/11/2014 10:50:00 AM - Zacks.com


Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
8/6/2014 4:45:00 PM - Zacks.com


Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog
8/6/2014 4:00:00 PM - Zacks.com


Should You Buy Anacor Pharmaceuticals (ANAC) Ahead of Earnings? - Tale of the Tape
8/6/2014 7:48:30 AM - Zacks.com


Is Tenet Healthcare (THC) Poised to Beat Earnings in Q2? - Analyst Blog
8/1/2014 3:55:00 PM - Zacks.com